Active ingredient: AL-LAD
Active to: 30 - 60 min. After oral / sublingual administration
Active time: 5 - 12 hours
Quality: 0.1mg,> = 99% pure, AL-LAD (6-Allyl-6-nor-lysergic acid diethylamide)

Hallucinatory states
AL-LAD is capable of producing a full range of low and high level hallucinatory states in a fashion that is a less consistent and reproducible than that of many other commonly used psychedelics such as psilocin or DMT but considerably more likely to when compared to that of LSD. This can feel similar to the hallucinations which occur with 4-AcO-DMT but tends to occur almost exclusively at heavier doses.


While its subjective effects largely overlap with those of LSD, AL-LAD is commonly reported to be significantly shorter in its duration and less uncomfortable in both its negative physical side effects and general anxiety. Some users have proposed that this compound could potentially serve as an effective introductory psychedelic, alongside other shorter-lasting and manageable psychedelics like 2C-B or 4-HO-MET.

The effects listed below are based upon the subjective effects index and personal experiences of PsychonautWiki contributors. These effects should be taken with a grain of salt and will rarely (if ever) occur all at once, but heavier doses will increase the chances of inducing a full range of effects. Likewise, adverse effects become much more likely on higher doses and may include serious injury or death


6-Allyl-6-nor-lysergic acid diethylamide (also known as N-allyl-nor-lysergic acid N,N-diethylamide,[1] N-allyl-nor-LSD,[1] or commonly as AL-LAD[1]) is a novel psychedelic substance of the lysergamide class. AL-LAD is chemically similar to LSD and has a similar mechanism of action, working primarily by binding to serotonin receptors in the brain.

AL-LAD was first investigated in 1984 by Andrew J. Hoffman and David Nichols as part of a series of LSD analogs, which also included ETH-LAD and PRO-LAD.[2] Its activity in humans was later documented by Alexander Shulgin in his book TiHKAL ("Tryptamines I Have Known and Loved"), in which it is described as "considerably less dramatic".[3] In 2013, AL-LAD appeared for sale on the research chemical market,[4] where it has been commonly marketed alongside lysergamides such as 1P-LSD, ALD-52 and ETH-LAD as a legal, grey-market alternative to LSD.

User reports describe the effects of AL-LAD as similar to those of LSD with some subtle differences. It is thought to either be equally or moderately less potent than LSD itself, with an active dose reported at between 75 and 150 micrograms. It is often described as being more visually-oriented but with a less introspective headspace. It also has a moderately shorter duration and is generally considered to be a less anxiety-provoking and challenging version of LSD.

100x AL-LAD Blotter 70ug (Light) LSD Print

100x AL-LAD Blotter 70ug (Light) LSD Print

100x AL-LAD Blotter 70ug (Light) LSD PrintLayout: LSD PrintQuantity: 100 (1 Unit = 1 Pic)Dosage:&nbs..


50x AL-LAD Blotter 70ug (Light) LSD Print

50x AL-LAD Blotter 70ug (Light) LSD Print

50x AL-LAD Blotter 70ug (Light) LSD PrintLayout: LSD PrintQuantity: 50 (1 Unit = 1 Pic)Dosage: ..


Showing 1 to 2 of 2 (1 Pages)